Dr. Audrey Coilly obtained her medical degree in 2009. She has been a Fellow since 2009, at the Centre Hepato-Biliaire, Paul Brousse hospital, Villejuif, France. Her clinical areas of expertise include hepatology, liver transplantation, and specifically the use of new direct antiviral agents (DAA) after liver transplantation for HCV recurrence. Dr. Coilly is currently a PhD student and her current research interests include proteomic and role of tetraspanin in hepatocarcinogenesis. Starting last year, she has been coordinating an European multicentric study concerning the use of DAA after liver transplantation (CUPILT), within the National Research Network in HIV and Viral Hepatitis (ANRS).